• Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Center for Arms Control and Non-Proliferation

Center for Arms Control and Non-Proliferation

  • Policy Issues
    • Fact Sheets
    • Countries
    • Nuclear Weapons
    • Non-Proliferation
    • Nuclear Security
    • Biological & Chemical Weapons
    • Defense Spending
    • Missile Defense
    • No First Use
  • Nukes of Hazard
    • Podcast
    • Blog
      • Next Up In Arms Control
    • Videos
  • Join Us
  • Press
  • About
    • Staff
    • Boards & Experts
    • Jobs & Internships
    • Financials and Annual Reports
    • Contact Us
  • Donate
  • Search
You are here: Home / Biological and Chemical Weapons / Amid the Turmoil of Covid, Biosafety Legislation Gets Political

June 27, 2022

Amid the Turmoil of Covid, Biosafety Legislation Gets Political

Greg Koblentz, member of the Scientists Working Group, was quoted in Undark.

Reforms are receiving “a lot more attention,” said Gregory Koblentz, a biodefense expert at George Mason University. But, he added, “the part that really concerns me right now is this kind of hyper-partisan polarization of this issue, which might make it harder to translate the level of concern that people are expressing into an effective policy response.”

…

Behind the scenes in Washington, some policy analysts say, there’s interest in new biosafety legislation among lawmakers in both parties. But building political capital can be difficult. “These issues are not really of concern to the average voter,” said Koblentz. “People don’t get elected because they improve biosafety. It’s just too narrow and technical of an issue — unless you can tie it to some higher partisan issue, which is what Republicans have done.”

In recent remarks to the Bipartisan Commission on Biodefense, a nonprofit group, Koblentz warned that the stakes of inaction are only getting higher: New developments in genome editing, synthetic biology, and other fields could pose fresh risks. More private companies are doing work in this area, often with virtually no public scrutiny. And the pandemic, he predicted, would lead to a surge in pathogen research — fueling a growth of BSL-3 and BSL-4 laboratories in countries that have limited biosafety oversight. It’s time, he wrote, for reforms at home — and for a “new global architecture for biorisk management.”

Posted in: Biological and Chemical Weapons

Primary Sidebar

Recent Posts

  • Strengthening Biosecurity Efforts Without the Federal Government June 18, 2025
  • لماذا وسّعت إسرائيل أهدافها إلى منشآت الطاقة الإيرانية؟ June 15, 2025
  • Report: Global Nuclear Weapons Spending Surpassed $100 Billion Last Year June 13, 2025
  • Обстрелы Израиля и месть Ирана ][ Протесты в Калифорнии — только начало? June 13, 2025
  • Fact Sheet: The Arms Trade Treaty June 9, 2025

Footer

Center for Arms Control and Non-Proliferation

820 1st Street NE, Suite LL-180
Washington, D.C. 20002
Phone: 202.546.0795

Issues

  • Fact Sheets
  • Countries
  • Nuclear Weapons
  • Non-Proliferation
  • Nuclear Security
  • Defense Spending
  • Biological and Chemical Weapons
  • Missile Defense
  • No First Use

Countries

  • China
  • France
  • India and Pakistan
  • Iran
  • Israel
  • North Korea
  • Russia
  • United Kingdom

Explore

  • Nukes of Hazard blog
  • Nukes of Hazard podcast
  • Nukes of Hazard videos
  • Front and Center
  • Fact Sheets

About

  • About
  • Meet the Staff
  • Boards & Experts
  • Press
  • Jobs & Internships
  • Financials and Annual Reports
  • Contact Us
  • Council for a Livable World
  • Twitter
  • YouTube
  • Instagram
  • Facebook

© 2025 Center for Arms Control and Non-Proliferation
Privacy Policy

Charity Navigator GuideStar Seal of Transparency